Related Experiment Video
Updated: May 8, 2026
08:06
Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
Published on: November 10, 2016
Pharmacy compounding urban legends.
1Clinical IQ, LLC, Florham Park, New Jersey.
International Journal of Pharmaceutical Compounding
|August 27, 2013
Summary
This article clarifies myths about pharmaceutical compounding, including sterile compounding standards and environmental concerns. It recommends collaboration between pharmacists and manufacturers for safer compounded medications.
Area of Science:
- Pharmaceutical Sciences
- Drug Compounding
- Quality Assurance
Background:
- Myths and misconceptions surrounding pharmaceutical compounding can impact medication safety and efficacy.
- Understanding regulatory guidelines, such as United States Pharmacopeia (USP) Chapter 797, is crucial for sterile compounding.
- Environmental factors play a significant role in maintaining the integrity of compounded sterile preparations.
Purpose of the Study:
- To review and clarify common myths and urban legends associated with pharmaceutical compounding.
- To provide insights into United States Pharmacopeia (USP) Chapter 797 guidelines relevant to compounding.
- To highlight environmental considerations in sterile compounding practices.
Main Methods:
- Literature review and analysis of existing information on pharmaceutical compounding myths.
- Discussion of United States Pharmacopeia (USP) Chapter 797 standards.
- Identification and commentary on environmental factors affecting sterile compounding.
Main Results:
- Several common myths regarding pharmaceutical compounding were identified and debunked.
- Clarification provided on USP Chapter 797 requirements and their application.
- Emphasis placed on the importance of environmental controls in sterile compounding.
Conclusions:
- A knowledge-based partnership between compounding pharmacists and pharmaceutical manufacturers is recommended.
- Improved compounding activities and quality assurance methods are essential for ensuring medication safety.
- Addressing myths and misconceptions enhances the overall safety and quality of compounded medications.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...